These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7860652)

  • 1. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists.
    Warner DS; Martin H; Ludwig P; McAllister A; Keana JF; Weber E
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):188-96. PubMed ID: 7860652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
    Takaoka S; Bart RD; Pearlstein R; Brinkhous A; Warner DS
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
    Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
    Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural neurotoxicologic investigation of the glycine antagonist 5-nitro-6,7-dichloroquinoxalinedione (ACEA-1021).
    Auer RN
    Neurotoxicology; 1997; 18(1):53-62. PubMed ID: 9215988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia.
    Nishiyama T
    Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine site NMDA receptor antagonists provide protection against ischemia-induced neuronal damage in hippocampal slice cultures.
    Newell DW; Barth A; Malouf AT
    Brain Res; 1995 Mar; 675(1-2):38-44. PubMed ID: 7796152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-methyl-D-aspartate (NMDA) receptor glycine site antagonist ACEA 1021 does not produce pathological changes in rat brain.
    Hawkinson JE; Huber KR; Sahota PS; Han Hsu H; Weber E; Whitehouse MJ
    Brain Res; 1997 Jan; 744(2):227-34. PubMed ID: 9027382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycine receptor antagonism. Effects of ACEA-1021 on the minimum alveolar concentration for halothane in the rat.
    McFarlane C; Warner DS; Nader A; Dexter F
    Anesthesiology; 1995 Apr; 82(4):963-8. PubMed ID: 7717569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituted analogues of GV150526 as potent glycine binding site antagonists in animal models of cerebral ischemia.
    Di Fabio R; Conti N; De Magistris E; Feriani A; Provera S; Sabbatini FM; Reggiani A; Rovatti L; Barnaby RJ
    J Med Chem; 1999 Sep; 42(18):3486-93. PubMed ID: 10479281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuroprotective effect of the glycine site antagonist 3R-(+)-cis-4-methyl-HA966 (L-687,414) in a rat model of focal ischaemia.
    Gill R; Hargreaves RJ; Kemp JA
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):197-204. PubMed ID: 7860653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
    Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.
    Banks P; Franks NP; Dickinson R
    Anesthesiology; 2010 Mar; 112(3):614-22. PubMed ID: 20124979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T; Marshall GR; Hill RG; Kemp JA
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site.
    Hood WF; Gray NM; Dappen MS; Watson GB; Compton RP; Cordi AA; Lanthorn TH; Monahan JB
    J Pharmacol Exp Ther; 1992 Aug; 262(2):654-60. PubMed ID: 1386886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-D-aspartate receptor.
    Lingenhöhl K; Pozza MF
    Neuropharmacology; 1998 Jun; 37(6):729-37. PubMed ID: 9707286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
    Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
    Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia.
    Gill R
    Cerebrovasc Brain Metab Rev; 1994; 6(3):225-56. PubMed ID: 7529037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.